Today, the FDA issued draft guidance outlining a new regulatory pathway intended to help sponsors gain approval for highly ...
The framework, first introduced by FDA Commissioner Marty Makary and Center for Biologics Evaluation and Research head Vinay ...
Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non–Small-Cell Lung Cancer? In the article that accompanies ...
Boston Vitality, a medical practice located in Stoneham, Massachusetts, outlines its structured approach to testosterone ...
Clinical Trials Arena on MSN
Gene editing takes centre stage in FDA’s new rare disease approval pathway
The aim of the pathway is to remove red tape for bespoke therapies designed for patients with rare diseases.
LAS VEGAS, NV, UNITED STATES, February 11, 2026 / EINPresswire.com / — Mentavi Health, a provider of evidence-based digital mental health care, will participate in the 31st Annual National ...
Despite advances in clinical cancer care, cancer survivors frequently report a range of persisting issues, unmet needs, and concerns that limit their ability to participate in life roles and reduce ...
The FDA released a much-anticipated draft guidance on how makers of rare disease genetic medicines can leverage a platform ...
The IMROZ and PERSEUS trials revealed significant underrepresentation of Black patients, despite their high incidence of multiple myeloma. Broader underrepresentation of minority groups in clinical ...
Cyprus presidency seeks to establish a European centre addressing persistent structural gaps in the EU's HTA health system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results